Blog

Aakash Desai: ASCO25 set to showcase some innovative SCLC LCSM Research

Aakash Desai/LinkedIn

Jun 2, 2025, 13:13

Aakash Desai: ASCO25 set to showcase some innovative SCLC LCSM Research

Aakash Desai, Assistant Professor and Associate Director of Phase 1 and Precision Oncology Program at the UAB O’Neal Comprehensive Cancer Center, shared a post on LinkedIn:

“American Society of Clinical Oncology (ASCO) set to showcase some innovative SCLC LCSM research, hopefully pushing boundaries in this field!

Improving outcomes for LCSM is a critical need!
Current management algorithm for SCLC and,
Studies being presented and where they may fit in?”

Aakash Desai highlighted the upcoming presentation of novel small cell lung cancer research at ASCO. He emphasized the need for better treatment outcomes in limited-stage SCLC and the importance of integrating new findings into clinical practice.

More posts featuring Aakash Desai.

Aakash Desai American Society of Clinical Oncology ASCO25 cancer fight against cancer Global fight against cancer LCSM Research OncoDaily Oncology SCLC

MiNK Therapeutics Stock Surges on Breakthrough Testicular Cancer Remission and iNKT Cell Therapy Progress

Tabelecleucel (Ebvallo) FDA Update: Approval Delayed Despite Positive Phase 3 Data

New Paper Alert: Breakthrough iNKT Cell Therapy Achieves Complete Remission in Metastatic Germ Cell Tumor

"God Invented This" - Pat Soon-Shiong on Cancer Discovery

Kevin Conroy: Oncodetect is Now Covered by Medicare in Stage IV Colorectal Cancer